scispace - formally typeset
J

Jean-Marie Rakic

Researcher at University of Liège

Publications -  57
Citations -  2609

Jean-Marie Rakic is an academic researcher from University of Liège. The author has contributed to research in topics: Choroidal neovascularization & Angiogenesis. The author has an hindex of 20, co-authored 51 publications receiving 2412 citations. Previous affiliations of Jean-Marie Rakic include Sanofi S.A..

Papers
More filters
Journal ArticleDOI

Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization

TL;DR: Observations demonstrate the participation of PlGF in experimental CNV and identify therefore PlGF as an additional promising target for ocular antiangiogenic strategies.
Journal ArticleDOI

Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.

TL;DR: This standardized protocol can be applied to transgenic mice and can include treatments with drugs, recombinant proteins, antibodies, adenoviruses and pre-microRNAs to aid in the search for new molecular regulators and the identification of novel targets for innovative treatments.
Journal ArticleDOI

Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease.

TL;DR: It is shown that PlGF blockage inhibits vessel abnormalization rather than density in certain tumors while enhancing VEGF-targeted inhibition in ocular disease and warrant further testing of anti-PlGF therapies.
Journal ArticleDOI

MicroRNA-21 exhibits antiangiogenic function by targeting RhoB expression in endothelial cells.

TL;DR: The results identify miR-21 as a new angiogenesis inhibitor and suggest that inhibition of cell migration and tubulogenesis is mediated through repression of RhoB.
Journal ArticleDOI

MMP-2 and MMP-9 synergize in promoting choroidal neovascularization

TL;DR: MMP‐2 and MMP‐9 may cooperate in the development of AMD and that their selective inhibition represents an alternative strategy for the treatment of choroidal neovascularization is suggested.